This story has been updated from a previous version to include comments from Quidel's earnings call.

NEW YORK (GenomeWeb) –  Quidel reported after the close of the market on Wednesday that its second quarter revenues dropped 2 percent year over year, driven by a decline in influenza-related testing.

For the three months ended June 30, the company reported that revenues dropped to $38.3 million from $39.1 million in Q2 2016, and missed the average analysts' estimate of $41.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.